10 February 2026
10 July 2026
15 September 2026
Not yet published
✨ AI summary
The buyer is seeking pragmatic clinical trials to optimize immunotherapeutic interventions. These trials are intended for patients with refractory cancers. The goal is to improve treatment outcomes for these patients through immunotherapeutic interventions.
Original notice
View on source ↗Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Reproduced verbatim from the official notice — only the wording is the source's; we split it into sections for readability.
Reference imagery
Illustrative only — not photos of this specific project.
Related tenders